FDA advisers recommend approval of controversial ALS drug

Unbiased advisers to the Meals and Drug Administration voted 7-2 on Wednesday to advocate approval of an experimental ALS drug with sturdy assist from sufferers and advocates, making it seemingly the extremely controversial therapy will likely be permitted by the company in a number of weeks. The vote was a surprising reversal from late March … Read more